Legal
The price of a single pill went up from 16p to 9.22 pounds, even though production costs remained broadly stable during that period, the CMA said.
Genentech is claiming that Pfizer’s proposed biosimilar infringes 40 of its patents.
The hearing will focus on the therapeutic potential and ethical issues of using CRISPR technology to alter human DNA.
The FDA issued warning letters to Lupin for two of its manufacturing facilities in Goa and Pithampur, Indore.
Harris fired the first shots on Monday.
Baker and ex-ArthroCare CFO Michael Gluk were convicted in June 2014 on charges that they ran a scheme to generate false revenue numbers
Osiris has settled a case of accounting fraud with the U.S. SEC, but four former company execs will face charges for the alleged financial misreporting.
Mylan’s second-ranked exec allegedly took an active role in a vast and “sinister” price-fixing conspiracy among global makers of generic pills.
Insys continues to receive an optics beating in the wake of the charges against company founder John Kapoor and multiple executives surrounding illegal sales practices of its cancer pain drug.
Last week a federal judge asked prosecutors and the FBI to look into possible witness tampering.
PRESS RELEASES